Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.63%
median of 784 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$18.65M
Gross Margin
43.54%
TTM Avg
69.65%
3Y Avg
34.83%
5Y Avg
-433.64%
Market Cap
$19.53M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.67M
Gross Margin
-9.89%
TTM Avg
45.05%
3Y Avg
72.53%
5Y Avg
64.22%
Market Cap
$20.01M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$17.73M
Gross Margin
10.27%
TTM Avg
10.01%
3Y Avg
10.00%
5Y Avg
11.56%
Market Cap
$17.23M
Gross Margin
-334.26%
TTM Avg
-117.13%
3Y Avg
-347.18%
5Y Avg
-222.70%
Market Cap
$17.01M
Gross Margin
0.00%
TTM Avg
-52.16%
3Y Avg
-139.89%
5Y Avg
-776.52%
Market Cap
$16.98M
Gross Margin
-354.93%
TTM Avg
-228.26%
3Y Avg
-369.25%
5Y Avg
-249.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $18.95M | 0.00% | 0.00% | 0.00% | 0.00% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | 43.54% | 69.65% | 34.83% | -433.64% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| P3 Health Partners Inc. (PIII)vs › | $19.67M | -9.89% | 45.05% | 72.53% | 64.22% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cosmos Health Inc. (COSM)vs › | $17.73M | 10.27% | 10.01% | 10.00% | 11.56% |
| Lipocine Inc. (LPCN)vs › | $17.23M | -334.26% | -117.13% | -347.18% | -222.70% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 0.00% | -52.16% | -139.89% | -776.52% |
| PAVmed Inc. (PAVM)vs › | $16.98M | -354.93% | -228.26% | -369.25% | -249.00% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 52.73% |
| 2019-12-31 | -468.43% |
| 2019-09-30 | -447.25% |
| 2019-06-30 | -445.15% |
| 2019-03-31 | -379.96% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
